SWF file not found. Please check the path.
سایر همایشهای انگليسي-مطالعات پايه در مورد HTLV (ويرولوژي،ايمونولوژي، ژنتيك و ...)
مرتب سازی بر اساس عنوان مطلب
مرتب سازی بر اساس تاریخ ایجاد
Unpublished
Title Filter
Display #
5
10
15
20
25
30
50
100
All
Evaluation of HTLV-I and host interaction on development of adult T cell leukemia/lymphoma: study of HBZ, RORγt, FOXP3 genes expression
High Level Soluble Expression and One-step Purification of HTLV-I p19 Protein in Escherichia coli by Fusion Expression (A-10-277-1)
Description of a virological marker in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I Associated Myelopathy (HAM-TSP) and Healthy Carriers (A-10-1327-1)
Serum Total Antioxidant Capacity Status of HTLV-1 Infected Patients (A-10-1267-1)
Evaluation of LAT and c-Fos expression in Adult T cell Lukemia/lymphoma and healthy carriers (A-10-1336-1)
Evaluation of TAX and BCL-XL gene expression in Adult T cell Leukemia/Lymphoma (ATL) and Healthy Carriers (A-10-1327-2)
A comparison on HTLV-I proviral load and clinical features of HAM/TSP among Iranian and Japanese (A-10-1484-1)
The impact of HTLV-I/HIV co-infection on HTLV-I proviral and HIV viral load (AA-10-1484-2)
HTLV-I and associated diseases: groups at risk in Europe
Molecular characterization of HTLV-I infection in Israel
HLA DRb genes contribute to susceptibility and resistance to HAM/TSP
Expression Of IL-2Ra Chain (CD25) On Peripheral Blood LymphocyteOf HAM/TSP Patients
Association between novel human perforin gene polymorphism and HTLV-I-associated/myelopathy tropical spastic paraparesis -HAM/TSP
Cytokine gene polymorphism in HTLV-I-associated myelopathy tropical spastic paraparesis-HAM/TSP
Evaluation of IL-2 receptor among HAM /TSP Patients and HTLV-I Carriers in Mashhad,Iran
Genetic analyses of HTLV-I from India and newly identified endemic Loci, Iranian Mashhad and Russia
HLA CLASS II-LINKED GENE CONTROLS SUSCEPTIBILITY TO HTLV-1 INFECTION IN IRANIAN JEWS IN ISRAEL
HTLV-1 in Kuwait: Close sequence homology with HTLV-1 originating in Mashhad region of Iran
IFN-a2b reduces released particles of HTLV-I from HTLV-I transformed cell line
Evaluation of immune markers profile of HTLV-1 infected people in northeast of Iran
Evaluation of activity markers of regulatory T cells and proviral load in HTLV-I-associated myelopathy/tropical spastic paraparesis patient activity
Comparison of IL-12, IL-18 and IFN-γ Gene Expression in HTLV-1-Associated Myelopathy ⁄ Tropical Spastic Paraparesis (HAM/TSP) Patients, HTLV-1 Carriers and HTLV-1 Negative Individuals
The Association between Serum Calcium and Vitamin D, HTLV-1 Proviral Load, and the Severity of HAM/ TSP Clinical Symptoms (P-41)
The Effect of HTLV-1 Virulence Factors (HBZ, Tax, Proviral Load), and Expression of CXCR3 and CCR6 and Their Ligands on Manifestation of HTLV-1 Associated Myelopathy Tropical Spastic Paraparesis (P-149)
Assessment the Activity of HTLV-1 in HAM/TSP Patients Using Tax mRNA Expression and Proviral Load After in Vitro Lymphocyte Activation (P-179)
Neurofilament Light Chain: A Possible Biomarker to Predict Development of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (P-293)
Assessment the Activity of HTLV-1 in HAM/TSP Patients Using Tax mRNA Expression and Proviral Load After in Vitro Lymphocyte Activation
Study of the Effects of Combined Therapy with Sodium Valproate, Peg-interferon and Corticosteroid on Proviral Load of HTLV-1 and Expression of Rel-A, Creb and IL-1 Genes in Patients with HTLV-1 Associated Spastic Paraparesis (HAM/TSP)
The Effects of Curcumin on Apoptosis and Cytotoxicity-Related Molecules in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients
Sequence and Phylogenetic Analysis of LTR region of Human T-Cell Lymphotropic Virus Type 1 from Mashhad, Iran
Evaluation of Gene and Protein Levels of IL-33 and Soluble Receptor (ST2-Receptor) Patients with HAM/TSP and HTLV-1 Carriers
HTLV-1 Infection Dampens NK cell Function
Melphalan cytotoxicity increased in combination with Arsenic trioxode in MT-2 lymphoma cells
Effects of melphalan on the expr ession of NF-κB in human lymphoma cells
Interaction of Perforin and Grnazyme Band HTLV-1 Viral factors Is Associated with ATLL development
Increased of PDGF-β gene expression is associated with ATLL development in HTLV-1 carriers
The effects of curcumin on gene expression and serum levels of Toll like receptor -2 &4 (TLR-2 and TLR-4) in patients with myelopathy associated with HTLV-1 (HAM/TSP) and virus carriers
Sequencing of HTLV1 p12 region in HAM/TSP, ATL patients and HTLV1 carriers in Mashhad, Iran
Cytotoxic and inflammatory markers determined the outcome of HTLV-1 infection
HTLV-1 infected asymptomatic carriers overexpress the cell-mediated cytotoxicity genes
Umbelliprenin cytotoxicity increased in combination with arsenic trioxode in MT-2 leukemia/lymphoma cells
Effects of sesquiterpene lactone parthenolide on the expr ession of NF-κB in human lymphoma cells
Parthenolide cytotoxicity increased in combination with Arsenic trioxode in MT2 lymphoma cells
Effects of Umbelliprenin on the expression of NF-κB in human leukemia/lymphoma cells
Evaluation of interleukin-1 beta (IL-1β), before and after curcumin treatment in HAM/TSP patients and HTLV-1 carriers
An Evaluation on HTLV-I Activity in HAM/TSP Patients before and after Triple Therapy (B-76)
Role of microRNAs in HTLV-1 infection
Purification and Seroprevalence of K55 Peptide Specific Antibodies among HTLV-ll Infected Serum in Mashhad Population (PB-060)
HTLV-I and host interaction on development of HTLV-associated myelopathy-tropical spastic paraparesis (HAM/TSP): study of HBZ, AKT1, BAD, IFN-λ3 genes expression (PV-23)
Evaluation for INOS gene expression a study in adult T cell leukemia malignancy associated with HTLV-1 (PV-26)
Bioinformatics analysis and structural alignment of HTLV-1 integrase protein (PV-43)
The evaluation of FOXP3 and GITR gene expression in ATL patients before and after treatment with triple arsenic regimen using real time PCR TaqMan method
The role of Th1 and Th2 cytokines in immune response to HTLV-1 associated myelopathy/tropical spastic paraparesis
Viral and host genetic factors that determine the development of Ham/Tsp
Zidovudine and Interferon-α Treatment Reduces Vascular Endothelium Growth Factor in Patients with Adult T- Cell Leukemia